Theraclone Sciences competitors

Theraclone Sciences Competitors include Clementia Pharmaceuticals, Cord Blood America, Synthace and InVitae.
Add company...
Theraclone Sciences
A privately-held biotechnology company focused on developing novel tumor- specific therapeutic antibodies for the treatment of cancer and infectious disease.
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
InVitae
InVitae provides genetic diagnostics for hereditary disorders.
Founding Date
Founding Date
2004
Founding Date
2012
Founding Date
1999
Founding Date
2011
Founding Date
2010
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Westmount, CA HQ
Newton, US
Locations
Las Vegas, US HQ
Locations
London, GB HQ
Locations
San Francisco, US HQ
Employees
Employees
713% decrease
Employees
482% increase
Employees
15
Employees
474% increase
Employees
50940% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
8.5 m
Valuation ($)
N/A
Valuation ($)
916.3 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
66
Facebook likes
23.5 k
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
506
Twitter followers
5.3 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$68.2m (FY, 2017)
Net income
Net income
N/A
Net income
($57.5m) (FY, 2016)
Net income
$102.2k (FY, 2016)
Net income
(£361.6k) (FY, 2013)
Net income
($123.4m) (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 3.1m (over 3 years ago)
Latest funding round
$ 60m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 9.9m (about 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 58.2m
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
$ 16.2m
Total funding raised
$ 195.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
48↑ 2% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
Cord Blood America
HQ
Las Vegas, US
Employees
15

Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.

View company
Synthace
HQ
London, GB
Employees
47↑ 4% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
InVitae
HQ
San Francisco, US
Employees
509↑ 40% increase

InVitae provides genetic diagnostics for hereditary disorders.

View company